secwatch.observer — SEC 8-K summary
======================================

Issuer:     QuidelOrtho Corp (QDEL)
CIK:        0001906324
Form:       8-K
Filed at:   2025-02-12T23:59:59+00:00
Accession:  0001906324-25-000031
Event type: earnings
Sentiment:  neutral
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

QuidelOrtho Q4 GAAP loss $2.28/sh; FY2024 rev $2.78B; guides FY25 rev $2.60-$2.81B, adj EBITDA margin 22%
--------------------------------------------------------------------------------

- Q4 GAAP diluted loss per share $2.28 vs EPS $0.10 prior year; adjusted EPS $0.63 vs $1.17.
- Q4 revenue $708M, down 5% YoY; non-respiratory flat; Labs revenue grew 4% ex-COVID and non-core.
- Full-year GAAP net loss $2.03B includes $1.82B goodwill impairment; adjusted EBITDA $543M, margin 19.5%.
- FY2025 guidance: revenue $2.60-$2.81B, adjusted EBITDA $575-$615M, adjusted diluted EPS $2.07-$2.57.
- Company cites cost-savings initiatives targeting incremental margin improvement and 22% adjusted EBITDA margin in 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1906324/000190632425000031/0001906324-25-000031-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1906324/000190632425000031/qdel-20250212.htm
  HTML page:      https://secwatch.observer/filing/0001906324-25-000031

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer